{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:34:32Z","timestamp":1762176872805,"version":"3.40.5"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["CA168778","DA032533","DA034699","UL1TR001086"],"award-info":[{"award-number":["CA168778","DA032533","DA034699","UL1TR001086"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","alcoholjournal.org","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Alcohol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.alcohol.2016.02.006","type":"journal-article","created":{"date-parts":[[2016,3,17]],"date-time":"2016-03-17T03:43:36Z","timestamp":1458186216000},"page":"45-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["An open-label pilot study of quetiapine plus mirtazapine for heavy drinkers with alcohol use disorder"],"prefix":"10.1016","volume":"53","author":[{"given":"Mary F.","family":"Brunette","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah C.","family":"Akerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ree","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7935-9133","authenticated-orcid":false,"given":"Christopher D.","family":"O'Keefe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan I.","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.alcohol.2016.02.006_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s40429-014-0034-7","article-title":"Pharmacotherapy of co-occurring schizophrenia and substance use disorders","volume":"1","author":"Akerman","year":"2014","journal-title":"Current Addiction Reports"},{"key":"10.1016\/j.alcohol.2016.02.006_bib2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/hup.935","article-title":"Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study","volume":"23","author":"Altintoprak","year":"2008","journal-title":"Human Psychopharmacology"},{"key":"10.1016\/j.alcohol.2016.02.006_bib3","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial","volume":"295","author":"Anton","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.alcohol.2016.02.006_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1527-3458.2001.tb00198.x","article-title":"A\u00a0review of the pharmacological and clinical profile of mirtazapine","volume":"7","author":"Anttila","year":"2001","journal-title":"CNS Drug Reviews"},{"key":"10.1016\/j.alcohol.2016.02.006_bib5","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A\u00a0rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.alcohol.2016.02.006_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/0269881103174013","article-title":"The Barnes akathisia rating scale\u2013revisited","volume":"17","author":"Barnes","year":"2003","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.alcohol.2016.02.006_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/JCP.0000000000000259","article-title":"The effects of mirtazapine versus placebo on alcohol consumption in male high consumers of alcohol: a randomized, controlled trial","volume":"35","author":"de Bejczy","year":"2015","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.alcohol.2016.02.006_bib8","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.amepre.2011.06.045","article-title":"Economic costs of excessive alcohol consumption in the U.S., 2006","volume":"41","author":"Bouchery","year":"2011","journal-title":"American Journal of Preventive Medicine"},{"key":"10.1016\/j.alcohol.2016.02.006_bib9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/schbul\/sbl003","article-title":"Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders","volume":"32","author":"Brunette","year":"2006","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.alcohol.2016.02.006_bib10","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.neuropharm.2011.05.007","article-title":"Raclopride lessens the ability of clozapine to suppress alcohol drinking in Syrian golden hamsters","volume":"61","author":"Chau","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.alcohol.2016.02.006_bib11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.neuropharm.2009.10.006","article-title":"Clozapine chronically suppresses alcohol drinking in Syrian golden hamsters","volume":"58","author":"Chau","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.alcohol.2016.02.006_bib12","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.alcohol.2013.10.002","article-title":"The comparative effects of clozapine versus haloperidol on initiation and maintenance of alcohol drinking in male alcohol-preferring P rat","volume":"47","author":"Chau","year":"2013","journal-title":"Alcohol"},{"key":"10.1016\/j.alcohol.2016.02.006_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jpsychires.2015.07.010","article-title":"Desipramine enhances the ability of paliperidone to decrease alcohol drinking","volume":"69","author":"Chau","year":"2015","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.alcohol.2016.02.006_bib14","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/15504263.2012.696527","article-title":"Mirtazapine in comorbid major depression and alcohol dependence: an open-label trial","volume":"8","author":"Cornelius","year":"2012","journal-title":"Journal of Dual Diagnosis"},{"key":"10.1016\/j.alcohol.2016.02.006_bib15","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.eurpsy.2006.04.007","article-title":"Quetiapine in relapse prevention in alcoholics suffering from craving and affective symptoms: a case series","volume":"21","author":"Croissant","year":"2006","journal-title":"European Psychiatry"},{"key":"10.1016\/j.alcohol.2016.02.006_bib16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/oxfordjournals.schbul.a033464","article-title":"The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia","volume":"26","author":"Drake","year":"2000","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.alcohol.2016.02.006_bib17","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.1530-0277.1999.tb04349.x","article-title":"Psychometric properties of the Penn alcohol craving scale","volume":"23","author":"Flannery","year":"1999","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1016\/j.alcohol.2016.02.006_bib18","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.293.13.1617","article-title":"Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial","volume":"293","author":"Garbutt","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.alcohol.2016.02.006_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0920-9964(02)00231-1","article-title":"Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone","volume":"60","author":"Green","year":"2003","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.alcohol.2016.02.006_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.psychres.2004.05.005","article-title":"Clozapine reduces alcohol drinking in Syrian golden hamsters","volume":"128","author":"Green","year":"2004","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.alcohol.2016.02.006_bib21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/10673229909017206","article-title":"Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?","volume":"6","author":"Green","year":"1999","journal-title":"Harvard Review of Psychiatry"},{"key":"10.1016\/j.alcohol.2016.02.006_bib22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.psychres.2014.04.038","article-title":"Desipramine enhances the ability of risperidone to decrease alcohol intake in the Syrian golden hamster","volume":"218","author":"Gulick","year":"2014","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.alcohol.2016.02.006_bib23","series-title":"048 HAMA Hamilton Anxiety Scale","first-page":"194","author":"Guy","year":"1976"},{"key":"10.1016\/j.alcohol.2016.02.006_bib24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0165-0327(98)00223-7","article-title":"Acute and long-term actions of the antidepressant drug mirtazapine on central 5-HT neurotransmission","volume":"51","author":"Haddjeri","year":"1998","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.alcohol.2016.02.006_bib25","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/archpsyc.64.7.830","article-title":"Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the Epidemiological Survey on Alcohol and Related Conditions","volume":"64","author":"Hasin","year":"2007","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.alcohol.2016.02.006_bib26","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1038\/sj.npp.1301646","article-title":"N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity","volume":"33","author":"Jensen","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.alcohol.2016.02.006_bib27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bcp.2007.08.005","article-title":"Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings","volume":"75","author":"Johnson","year":"2008","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.alcohol.2016.02.006_bib28","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/j.1530-0277.2011.01523.x","article-title":"The efficacy of disulfiram for the treatment of alcohol use disorder","volume":"35","author":"J\u00f8rgensen","year":"2011","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1016\/j.alcohol.2016.02.006_bib29","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/JCP.0b013e3180ca86e5","article-title":"A\u00a0double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism","volume":"27","author":"Kampman","year":"2007","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.alcohol.2016.02.006_bib30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.drugalcdep.2015.04.003","article-title":"Clozapine reconstructed: Haloperidol's ability to reduce alcohol intake in the Syrian golden hamster can be enhanced through noradrenergic modulation by desipramine and idazoxan","volume":"152","author":"Khokhar","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.alcohol.2016.02.006_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neuropharm.2016.01.017","article-title":"Effects of iloperidone, combined with desipramine, on alcohol drinking in the Syrian golden hamster","volume":"105","author":"Khokhar","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.alcohol.2016.02.006_bib32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/0269881104040241","article-title":"Mirtazapine improves alcohol detoxification","volume":"18","author":"Liappas","year":"2004","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.alcohol.2016.02.006_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pnpbp.2004.10.005","article-title":"Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification","volume":"29","author":"Liappas","year":"2005","journal-title":"Progress in Neuro-psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.alcohol.2016.02.006_bib34","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1530-0277.2011.01649.x","article-title":"A\u00a0double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patients","volume":"36","author":"Litten","year":"2012","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1016\/j.alcohol.2016.02.006_bib35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/01.jcp.0000106230.36344.b1","article-title":"Quetiapine for alcohol use and craving in bipolar disorder","volume":"24","author":"Longoria","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.alcohol.2016.02.006_bib36","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/hup.944","article-title":"Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics","volume":"23","author":"Martinotti","year":"2008","journal-title":"Human Psychopharmacology"},{"key":"10.1016\/j.alcohol.2016.02.006_bib37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1360-0443.1991.tb02627.x","article-title":"Calculating standard drink units: international comparisons","volume":"86","author":"Miller","year":"1991","journal-title":"British Journal of Addiction"},{"key":"10.1016\/j.alcohol.2016.02.006_bib38","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/jama.291.10.1238","article-title":"Actual causes of death in the United States, 2000","volume":"291","author":"Mokdad","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.alcohol.2016.02.006_bib39","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/01.jcp.0000138763.23482.2a","article-title":"Quetiapine for treatment of alcohol dependence","volume":"24","author":"Monnelly","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.alcohol.2016.02.006_bib40","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A\u00a0new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"The British Journal of Psychiatry"},{"issue":"Suppl. 13","key":"10.1016\/j.alcohol.2016.02.006_bib41","first-page":"5","article-title":"Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosing","volume":"63","author":"Nemeroff","year":"2002","journal-title":"The Journal of Clinical Psychiatry"},{"year":"2003","series-title":"Clozaril\u00ae (clozapine) prescribing information","key":"10.1016\/j.alcohol.2016.02.006_bib42"},{"key":"10.1016\/j.alcohol.2016.02.006_bib43","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0140-6736(09)60746-7","article-title":"Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders","volume":"373","author":"Rehm","year":"2009","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.alcohol.2016.02.006_bib44","first-page":"CD004332","article-title":"Acamprosate for alcohol dependence (Review)","author":"R\u00f6sner","year":"2011","journal-title":"Cochrane Database Systematic Review"},{"key":"10.1016\/j.alcohol.2016.02.006_bib45","first-page":"452","article-title":"Potential benefits of quetiapine in the treatment of substance dependence disorders","volume":"29","author":"Sattar","year":"2004","journal-title":"Journal of Psychiatry & Neuroscience"},{"issue":"Suppl. 1","key":"10.1016\/j.alcohol.2016.02.006_bib46","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.alcohol.2016.02.006_bib47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A\u00a0rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica. Supplementum"},{"key":"10.1016\/j.alcohol.2016.02.006_bib48","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0376-8716(96)01263-X","article-title":"The reliability of the Alcohol Timeline Followback when administered by telephone and by computer","volume":"42","author":"Sobell","year":"1996","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.alcohol.2016.02.006_bib49","series-title":"Measuring alcohol consumption: psychosocial and biochemical methods","first-page":"41","article-title":"Timeline follow-back: a technique for assessing self reported alcohol consumption","author":"Sobell","year":"1992"},{"year":"1995","series-title":"Timeline Followback Computer Software","author":"Sobell","key":"10.1016\/j.alcohol.2016.02.006_bib50"},{"key":"10.1016\/j.alcohol.2016.02.006_bib51","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1360-0443.1988.tb00485.x","article-title":"Reliability of a timeline method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations","volume":"83","author":"Sobell","year":"1988","journal-title":"British Journal of Addiction"},{"key":"10.1016\/j.alcohol.2016.02.006_bib52","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJM199712113372401","article-title":"Alcohol consumption and mortality among middle-aged and elderly U.S. adults","volume":"337","author":"Thun","year":"1997","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.alcohol.2016.02.006_bib53","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.pnpbp.2006.02.018","article-title":"Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: a multicentre, open label study","volume":"30","author":"Yoon","year":"2006","journal-title":"Progress in Neuro-psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.alcohol.2016.02.006_bib54","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/S0140-6736(09)61034-5","article-title":"Alcohol and cause-specific mortality in Russia: a retrospective case-control study of 48,557 adult deaths","volume":"373","author":"Zaridze","year":"2009","journal-title":"Lancet"}],"container-title":["Alcohol"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741832915300070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741832915300070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T04:24:16Z","timestamp":1536899056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741832915300070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":54,"alternative-id":["S0741832915300070"],"URL":"https:\/\/doi.org\/10.1016\/j.alcohol.2016.02.006","relation":{},"ISSN":["0741-8329"],"issn-type":[{"type":"print","value":"0741-8329"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An open-label pilot study of quetiapine plus mirtazapine for heavy drinkers with alcohol use disorder","name":"articletitle","label":"Article Title"},{"value":"Alcohol","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alcohol.2016.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}